thenewsfacts.com
  • Home
  • Latest News
  • Trending News
  • Entertainment
  • Technology
  • Sports
  • Business
  • Health
thenewsfacts.comthenewsfacts.com
Font ResizerAa
Search
  • Home
  • Latest News
  • Trending News
  • Entertainment
  • Technology
  • Sports
  • Business
  • Health
Follow US
© thenewsfacts : All Rights Reserved.

Home » News in Brief: ICMR New Study to cheer COVAXIN- ated

Latest News

News in Brief: ICMR New Study to cheer COVAXIN- ated

TheNewsFacts
Last updated: August 28, 2021 1:33 pm
TheNewsFacts
Share
News in Brief: ICMR New Study to cheer COVAXIN- ated
SHARE

An ICMR New Study will cheer those who were administered COVAXIN. According to the study announced COVAXIN single dose to COVID survivor is equivalent to two doses for non-infected person says ICMR study.

One dose of COVAXIN is equivalent to unaffected people taking two doses of COVAXIN

It means people already infected by Covid taking a dose of COVAXIN is equivalent to unaffected people taking two doses of COVAXIN. Anti-body responses post Covaxin dose.

Earlier, the Indian Council of Medical Research (ICMR) conducted a study in Chennai that has shown that the Delta variant of coronavirus has the potential to infect both vaccinated and unvaccinated individuals, but it reduces mortality among the former group.

COVAXIN®, India’s indigenous COVID-19 vaccine by Bharat Biotech is developed in collaboration with the Indian Council of Medical Research (ICMR) – National Institute of Virology (NIV).

The indigenous, inactivated vaccine is developed and manufactured in Bharat Biotech’s BSL-3 (Bio-Safety Level 3) high containment facility.

The vaccine is developed using Whole-Virion Inactivated Vero Cell derived platform technology. Inactivated vaccines do not replicate and are therefore unlikely to revert and cause pathological effects. They contain dead virus, incapable of infecting people but still able to instruct the immune system to mount a defensive reaction against an infection.

Why develop Inactivated Vaccine?

Conventionally, inactivated vaccines have been around for decades. Numerous vaccines for diseases such as Seasonal Influenza, Polio, Pertussis, Rabies, and Japanese Encephalitis use the same technology to develop inactivated vaccines with a safe track record of >300 million doses of supplies to date. It is the well-established, and time-tested platform in the world of vaccine technology.

TAGGED: BHARAT BIOTECH COVAXIN, COVAXIN New Study, Covaxin News, Covaxin Update, ICMR Covaxin, ICMR New Study
Share This Article
Twitter Email Copy Link Print
Previous Article Fahadh Faasil Bald Look in Puspha is Intense, Menacing Fahadh Faasil Bald Look in Puspha is Intense, Menacing
Next Article Samuthiram Completes 20 years: 5 interesting facts about the film Samuthiram Completes 20 years: 5 interesting facts about the film

Your Trusted Source for Accurate and Timely Updates!

We're committed to providing accurate and unbiased news as it unfolds, earning the trust of a large audience. Stay informed with our news updates on the latest events and trends, keeping you ahead of the curve.
FacebookLike
TwitterFollow
InstagramFollow

Popular Posts

Eloelo Raises $13.5M to Power GenAI, Target 400M+ Indian Consumers

April 10, 2025: Eloelo, a social live streaming platform has secured $13.5 million in a…

By TheNewsFacts

ChatGPT’s Latest macOS Beta: Real-Time Coding Help and Smart Productivity

December 20, 2024: In an exciting development for OpenAI enthusiasts, the Artificial Research Organisation has…

By TheNewsFacts

Kesari Chapter 2 Review: Gripping Story, But a Tangled Glory

April 19, 2025: Kesari Chapter 2: The Untold Story of Jallianwala Bagh promises an emotional…

By SK Panicker

You Might Also Like

Bhool Chuk Maaf Box Office Report
Latest News

Bhool Chuk Maaf Crosses ₹54 Cr Globally in 7 Days

By NewsFacts Bureau
Bharat Biotech HILLCHOL
Latest News

Bharat Biotech’s Oral Cholera Vaccine HILLCHOL Demonstrates Success in Phase III Clinical Studies

By TheNewsFacts
Biovet Lumpy Skin Disease Vaccine Launched
Latest News

BIOLUMPIVAXIN: New Vaccine Now Available to Protect Livestock from LSD

By NewsFacts Bureau
Google AI First Accelerator 2025 India
Latest News

Google Opens 2025 India AI First Accelerator: $17B Opportunity for Startups

By NewsFacts Bureau
thenewsfacts thenewsfacts

About US


TheNewsFacts: Brings you the interesting facts, news facts and updates from India an the world across politics, tech, entertainment, business, tending, and more. We deliver what you love to read.
Top Categories
  • Latest News
  • Trending News
  • Paris Olympics 2024
  • Sports
  • Entertainment
  • Business
  • Technology
Usefull Links
  • About The News Facts
  • Latest News
  • Privacy Policy
  • Editorial Policy
  • Disclaimer
  • Contact Us
Follow us
Facebook Twitter Instagram

© thenewsfacts. All Rights Reserved.

Welcome Back!

Sign in to your account

Lost your password?